Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from STEM

Small step for Nature, giant leap across the gender gap: leading journal will make sex and gender reporting mandatory in research

Like in many aspects of life, there remains an undercurrent of sex bias against women in the STEM fields. And this bias has a negative impact on not only women, but men too – and those who don’t fit within a binary category.

The Conversation

Serial shonk nailed for $900,000 in legal first building case

Roberts methodically trashed Jesmond development after dispute about defects.

Newcastle Herald

Scores of blood cancer patients await matching blood stem cell donors

May 28 is observed as World Blood Cancer Day

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

You could soon be paid £50k to live on one of Scotland's stunning islands

The Scottish Government are hoping to stem the depopulation problem the islands are facing.

Daily Record

Rise in traffic violations: police step up drives

The police in Mysuru on Wednesday stepped up drives against traffic offences in a bid to stem the increasing number of violations being reported across the city.

The Hindu

How the actors of 'Reservation Dogs' find themselves in their characters

Given an array of seating options, the four young stars of "Reservation Dogs" pile onto a couch. They look sharp, dolled up for a photo session, but that doesn't stem their good-natured ribbing. But they settle down as "big sister" Devery Jacobs — at 28 by far the eldest of…

Los Angeles Times

Danone, Reckitt race to ramp up US baby formula supply amid shortage

Danone SA has been doubling shipments to the United States of Neocate formula for infants allergic to cow's milk while Enfamil maker Reckitt is also working to boost supplies amid a nationwide shortage, company executives said on Wednesday.

Reuters

Read news from The Economist, FT, and more,
with one subscription

Riverland grower has life-changing myeloma diagnosis after breaking his back

In February last year, David Coombs was diagnosed with myeloma, a complex blood cancer with no cure.

ABC News

The catastrophic success of China’s zero-COVID policy

For two years, it seemed as though China’s ruthless COVID-19 policy had paid off. After stumbling in its initial efforts to stem the pandemic, China’s rulers fixed a simple numeric target — zero COVID cases — and made sure everyone knew they had to reach it. The results looked severe…

Los Angeles Times

‘Most interest for Quad fellowship is from India’

Bengaluru

The Hindu

Beijing extends work-from-home 'requirement' for millions as COVID spreads

The Chinese capital extended its work-from-home requirement for many of its 22 million residents to stem a COVID-19 outbreak, while Shanghai deployed more testing and curbs to hold on to its hard-won "zero COVID" status after two months of lockdown.

Reuters

Mum's fear as son's shot at a normal life depends on a kind stranger

"My whole world was shaken"

Liverpool Echo

Baby formula crisis: Abbott enriched shareholders as factory needed repairs, records show

Economists condemn ‘rot’ in system after manufacturer issued billions in stock buybacks despite problems at Michigan factory

The Guardian - US

Rocket Pharma's Gene Therapy Shows 100% Overall Survival In Immune Deficiency Disorder

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) has announced topline safety and efficacy data from its Phase 2 trial of RP-L201 gene therapy in severe Leukocyte Adhesion Deficiency-I (LAD-I). Data were shared at the American Society of Gene and Cell Therapy. LAD-I is a disorder that causes the immune system to malfunction, resulting in immunodeficiency. Immunodeficiencies…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

A quest for significance gone horribly wrong – how mass shooters pervert a universal desire to make a difference in the world

Agonizing questions are being raised by the recent tragic shooting incident in Buffalo, New York, where 18-year-old Payton S. Gendron is alleged to have shot 10 people dead and wounded three. As in the recent years’ similar acts of horror at a synagogue in Pittsburgh, a Walmart in El Paso,…

Benzinga

Avrobio's Pompe Disease Gene Therapy Shows Efficacy, Safety In Preclinical Study

Avrobio Inc (NASDAQ:AVRO) announced preclinical data demonstrating the efficacy and safety of AVR-RD-03 gene therapy in infantile-onset Pompe disease. Pompe disease is a lysosomal disorder caused by a mutation in the GAA gene. The lack of the enzyme encoded by GAA results in a toxic buildup of glycogen throughout the body and central nervous system.…

Reuters

World Bank to offer $30 billion as Ukraine war threatens food security

The World Bank said on Wednesday it will make $30 billion available to help stem a food security crisis threatened by Russia's war in Ukraine, which has cut off most grain exports from the two countries.

Evening Standard

Four-day week on full pay offered in drive for more teachers

London South East Colleges hope to attract more candidates with the option of a compressed week

Get all your
news in one place.

100's of premium titles.
One news app.

Zenger

Fertility Hope: Frozen Testicular Tissue Still Viable After 2 Decades

Frozen testicular tissue can still make sperm 20 years later, according to scientists who say it can help young cancer patients to later have children.

Los Angeles Times

Commentary: California’s math education needs an update, but not the one proposed

California students’ math scores have lagged for years and only gotten worse during the pandemic.

The Times of India

New Sri Lanka PM to sell airline, print money to pay salaries

COLOMBO: Sri Lanka's new government plans to sell its national airline to stem losses, part of efforts to stabilize the nation's finances even as authorities are forced to print money to pay government salaries.

Benzinga

Magenta Therapeutics Reveals Encouraging Interim Data From Lowest Dose Of MGTA-117 In Leukemia Trial

Magenta Therapeutics Inc (NASDAQ:MGTA) shared preliminary data from the Phase 1/2 dose-escalation trial of MGTA-117 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome with excess blasts. The data comes from a Cohort 1, evaluating the lowest dose of MGTA-117 (0.02 mg/kg). Three patients completed the safety evaluation period. A fourth patient with…

Roll Call

Congress mulls immigration’s role in China competition strategy - Roll Call

House Democrats and advocates are pushing for immigration provisions that would attract high-skilled workers.

Zenger

House Cleaning: Study Finds Cells Take Out The Trash Before They Divide

The discovery was made using a new method the MIT team developed for measuring the dry mass of cells.

Axios

Scoop: U.S. to deny entry to some Afghans in Kosovo

The determinations stem from security concerns, or the identification of potential ties to the Taliban or terrorist organizations.

1 … 80 81 82 83

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Boston Children Hospital

37 stories

Royal Adelaide Hospital

Read news from The Economist, FT, and more,
with one subscription

Topics

International Students

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.